Publications (14) Publications in which a researcher has participated

filter_list Immunology

2024

  1. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 74-79

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

2022

  1. Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients

    Cells, Vol. 11, Núm. 3

  2. The lysosomal system: Physiology

    Lysosomal Storage Disorders: A Practical Guide (wiley), pp. 9-18

2021

  1. Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment

    Cells, Vol. 10, Núm. 2

2020

  1. Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB

    PLoS Pathogens, Vol. 16, Núm. 6 June

  2. The vitamin D receptor Taq I polymorphism is associated with reduced VDR and increased PDIA3 protein levels in human intestinal fibroblasts

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 202

  3. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors

    Antiviral Research, Vol. 178

2019

  1. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack

    Antiviral Research, Vol. 168, pp. 36-50

2017

  1. Cardiovascular toxicity of abacavir: A clinical controversy in need of a pharmacological explanation

    AIDS, Vol. 31, Núm. 13, pp. 1781-1795

  2. Coinfección virus de inmunodeficiencia humana-virus de la Hepatitis C: hacia un nuevo escenario terapéutico

    Revista Habanera de Ciencias Medicas, Vol. 16, Núm. 2, pp. 198-215

  3. Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects

    European Journal of Pharmacology, Vol. 812, pp. 163-173

2016

  1. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages

    Autophagy, Vol. 12, Núm. 8, pp. 1240-1258

  2. The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 916-926